Cuban Biotech Anomaly
conceptBiotech & Transhumanism
A cut-off, cash-starved island somehow makes cancer drugs the United States wants to import even while it blockades the place.
Who they are
Cuba's surprisingly advanced pharmaceutical and vaccine industry.
What they do
Despite being blockaded and poor, Cuba develops world-class medicines, which the engine flags as an anomaly worth noticing.
How it works
Cuba made its own COVID vaccines (Soberana/Abdala, reported 92.28% effective), a lung-cancer vaccine (CIMAvax) now in US trials at Roswell Park, a diabetic-foot treatment (Heberprot-P) cutting amputations, and the first meningitis-B vaccine. It also sends 22,000-28,000 doctors to 50-plus countries, earning an estimated $6-8 billion a year.
Why it matters
The US blockades the island while simultaneously seeking approval to import its cancer treatments, exposing a contradiction between the political line and the medical reality.
The engine's record — word for word
Blockaded island producing world-class pharmaceuticals. Soberana 02/Abdala: COVID vaccines 92.28% efficacy (Lancet), only domestically developed in Latin America. CIMAvax-EGF: therapeutic lung cancer vaccine, FDA-approved trials at Roswell Park. Heberprot-P: diabetic foot ulcer treatment reducing amputation 70%+, FDA Phase III (2024). VA-MENGOC-BC: worlds first MenB vaccine (1989). Medical diplomacy: 22,000-28,000 doctors in 50+ countries, $6-8B annual revenue. The US embargoes the island while seeking FDA approval to import its cancer treatments.
Follow the trail
Walk this on the live map →